MedTrace Logo

Relationship Between Gut Microbiome, Probiotics, and Mild Cognitive Impairment

NCT04971096 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-08-08

No results posted yet for this study

Summary

This study is to evaluate whether the consumption of probiotics can improve the symptoms of patients with mild cognitive impairment; also evaluate the effects of probiotics on patients' blood, oxidation and stress related indicators.

Conditions

  • Mild Cognitive Impairment (MCI)

Interventions

DIETARY_SUPPLEMENT

PS23 live

PS23 belongs to Lactobacillus paracasei group.Probiotic capsules contain 30 billion CFU (colony forming units) of PS23

DIETARY_SUPPLEMENT

PS23 heat-treated

The PS23 heat-treated probiotic capsule contain 30 billion of PS23 cells.

DIETARY_SUPPLEMENT

Placebo

The placebo capsule contains microcrystalline cellulose.

Sponsors & Collaborators

  • Bened Biomedical Co., Ltd.

    collaborator INDUSTRY

  • Mackay Memorial Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2024-01-16
Completion
2024-01-16

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04971096 on ClinicalTrials.gov